Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma
Clinical trial NCT07476066 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07476066
- Sponsor
- Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-15
- Primary completion
- 2029-03-15
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.